Johnson and Johnson/ US4781601046 /
08/11/2024 22:10:00 | Var. -1.26 | Volume | Denaro02:00:00 | Lettera02:00:00 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
155.47USD | -0.80% | 8.93 mill. Fatturato: 993.34 mill. |
155.40Quantità in denaro: 100 | 155.60Quantità in lettera: 200 | 374.31 bill.USD | 3.02% | 11.20 |
GlobeNewswire
28/05
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
GlobeNewswire
10/04
SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
GlobeNewswire
15/03
CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire
04/12/2023
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...